A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...
The combination of this new strategy with standard treatment also reduces the risk of metastasis. A vaccine based on messenger RNA (mRNA) technology reduces the possibility of melanoma recurrence by ...
A personalized mRNA vaccine may change melanoma treatment, with 70% of patients cancer-free after 5 years. Discover how this ...
An experimental vaccine from Moderna shows promise in keeping deadly skin cancer from returning for years, according to new ...
A doctor breaks down a new study on how mRNA vaccines in melanoma research could transform treatment and survival for cancer ...
What is an RNA vaccine? RNA vaccines, or messenger RNA (mRNA) vaccines, are a relatively new type of vaccine that delivers mRNA molecules to human cells, instructing them to produce specific antigens.
For patients with high-risk resected melanoma, adding the mRNA vaccine intismeran to pembrolizumab continued to stave off recurrence and distant metastases at 5 years.
Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.
As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results